Direct Oral Anticoagulants and Women
- PMID: 27706531
- DOI: 10.1055/s-0036-1592304
Direct Oral Anticoagulants and Women
Abstract
Direct oral anticoagulants (DOACs) provide an effective, safe, and convenient therapeutic alternative to warfarin and other vitamin K antagonists (VKAs), and are now established for a wide range of indications. The use of DOACs in women merits special consideration due to two main situations: first, in relation to fertility, pregnancy, and lactation in women of reproductive age; second, because of their bleeding risk, leading to abnormal uterine and/or other genital tract bleeding. This review focuses on these two clinical situations, including approaches to management in the context of available information.
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
